Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, ...
Using artificial intelligence, computers can watch surgeons perform operations and then write post-surgical operative notes ...
A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...
Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...
There are 16 chances to attend UniverSoul Circus's “Rhythm of the World” today through Feb. 23 under the big top tent at ...
Jim Ryan; Vice President - Investor Relations; Curtiss-Wright Corp. Lynn Bamford; Chairman of the Board, Chief Executive Officer; Curtiss-Wright Corp. K. Christopher ...
10hon MSN
As evidenced by this weekend’s flurry of festivities around its 50th anniversary, SNL has survived all the pot shots. Despite ...
Samsung Electronics recently announced that two health feature updates on its Galaxy Watch line-up are now available for the ...
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 21,829.91 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...
Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results